Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)
China flag China · Delayed Price · Currency is CNY
27.32
-0.06 (-0.22%)
Sep 1, 2026, 3:00 PM CST

SHA:603882 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
5,3325,4456,6277,72614,52911,304
Other Revenue
585.66585.66562.98813.43946.76639.52
5,9186,0307,1908,54015,47611,943
Revenue Growth
-6.15%-16.12%-15.81%-44.82%29.58%44.88%
Cost of Revenue
3,7813,9354,8075,4258,8026,295
Gross Profit
2,1372,0952,3833,1156,6745,648
Selling, General & Admin
1,4861,5271,5291,7302,5062,323
Research & Development
337.58341.28400.47467.14632.62517.93
Other Operating Expenses
24.4613.9415.9114.9114.7511.71
Operating Expenses
2,2182,2532,5642,7003,4092,924
Operating Income
-80.7-157.53-180.92414.933,2662,724
Interest Expense
-14.68-14.68-18.43-20.39-23.65-27.55
Interest & Investment Income
25.8224.3523.48288.3630.421.53
Currency Exchange Gain (Loss)
000.2-0.69.14-1.46
Other Non Operating Income (Expenses)
295.54-2.57-2.7-2.95-3.91-2.54
EBT Excluding Unusual Items
225.97-150.43-178.37679.353,2782,714
Impairment of Goodwill
-10.15-10.15----
Gain (Loss) on Sale of Investments
-14.02-3.63-140.82--10.8-7.29
Gain (Loss) on Sale of Assets
2.921.92-143.59-7.572.97-10.11
Asset Writedown
-0.08-----
Other Unusual Items
-19.32-19.3224.1468.5150.6450.87
Pretax Income
185.32-181.61-438.65740.293,3212,748
Income Tax Expense
55.43-3.01-23.94103.38475.72384.05
Earnings From Continuing Operations
129.89-178.6-414.7636.912,8452,364
Minority Interest in Earnings
-28.135.3633.466.47-90.22-143.87
Net Income
101.76-173.24-381.24643.382,7552,220
Net Income to Common
101.76-173.24-381.24643.382,7552,220
Net Income Growth
----76.64%24.11%47.02%
Shares Outstanding (Basic)
465468465466466462
Shares Outstanding (Diluted)
465468465466467466
Shares Change
0.00%0.71%-0.28%-0.15%0.13%1.00%
EPS (Basic)
0.22-0.37-0.821.385.914.80
EPS (Diluted)
0.22-0.37-0.821.385.904.76
EPS Growth
----76.61%23.95%45.57%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
642.62778.55459.99516.071,1071,136
Free Cash Flow Per Share
1.381.660.991.112.372.44
Dividend Per Share
0.8800.8800.8800.8801.7801.280
Dividend Growth
0%0%0%-50.56%39.06%289.06%
Gross Margin
36.11%34.74%33.15%36.48%43.13%47.29%
Operating Margin
-1.36%-2.61%-2.52%4.86%21.10%22.81%
Profit Margin
1.72%-2.87%-5.30%7.53%17.80%18.58%
Free Cash Flow Margin
10.86%12.91%6.40%6.04%7.16%9.51%
EBITDA
211.17159.65264.29866.663,6793,056
EBITDA Margin
3.57%2.65%3.68%10.15%23.77%25.59%
D&A For EBITDA
291.88317.18445.21451.73412.85331.56
EBIT
-80.7-157.53-180.92414.933,2662,724
EBIT Margin
-1.36%-2.61%-2.52%4.86%21.10%22.81%
Effective Tax Rate
29.91%--13.96%14.33%13.98%
Revenue as Reported
6,0306,0307,1908,54015,47611,943
Advertising Expenses
-3.540.762.163.293.16